<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2310-0265</journal-id>
<journal-title><![CDATA[Revista CON-CIENCIA]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Cs.Farm. y Bioq]]></abbrev-journal-title>
<issn>2310-0265</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Ciencias Farmacéuticas y BioquímicasUniversidad Mayor de San Andrés]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2310-02652025000200015</article-id>
<article-id pub-id-type="doi">10.53287/bfoi3796ig50o</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Validación de un método bioanalítico para la determinación de vancomicina en plasma humano por HPLC-UV y comparación con medidas obtenidas por LC-MS/MS]]></article-title>
<article-title xml:lang="en"><![CDATA[Analytical method for vancomycin determination in human plasma through HPLC-UV, using LC-MS/MS data comparison for its validation]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quezada Jácome]]></surname>
<given-names><![CDATA[Diana Fernanda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Linden]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Grando]]></surname>
<given-names><![CDATA[Ana Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pachar]]></surname>
<given-names><![CDATA[Samantha]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,aff1  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,aff2  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>13</volume>
<numero>2</numero>
<fpage>15</fpage>
<lpage>26</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2310-02652025000200015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2310-02652025000200015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2310-02652025000200015&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo. Validar un ensayo de cromatografía líquida fácilmente implementable para aplicación clínica en la monitorización terapéutica del fármaco vancomicina  Materiales y métodos. La vancomicina se extrajo del plasma, después de la precipitación de proteínas, con ácido perclórico y lavado con diclorometano. La separación se realizó en una columna de fase reversa con elución isocrática y detección ultravioleta. Para la comparación entre métodos se utilizó un banco de plasma del laboratorio de referencia y los resultados se analizaron a través del Software estadístico Medícale.  Resultados. El tiempo total de ejecución cromatográfica fue de 22 minutos. El ensayo fue lineal en el rango de 2.5 a 100 mcg/mL; la exactitud fue del 96,8 -113,6 %, la precisión intraensayo del 4,65 - 9,30 % y la precisión interensayo del 6,84 - 7,50 %. El ensayo se aplicó a 40 muestras de plasma almacenadas a -80 grados centígrados. Los resultados tuvieron una correlación positiva con ausencia de diferencias sistemáticas y proporcionales al ser comparados con el método de referencia LC - MS/MS.  Conclusiones. El ensayo fue validado y, gracias a su sencilla configuración, puede implementarse en laboratorios clínicos con el objetivo de individualizar farmacocinéticamente las dosis de vancomicina, presentando el método alta correlación con técnicas altamente sensibles. El método resultó selectivo, sensible y de fácil implementación.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective. To valídate a vancomycin monitoring assay through HPLC-UV for its clinical therapeutic application.  Materials and methods. Vancomycin was extracted from human plasma by protein precipitation using perchloric acid and dichloromethane wash. HPLC-UV separation was performed on a reverse-phase column with isocratic elution and UV detection. For method comparison, a human plasma was obtained from a reference laboratory and the results were analysed using Medícale statistical software.  Results. The HPLC-UV analysis time was 22 minutes. The assay was linear in the range of 2.5 to 100 mcg/mL; the aecuracy was 96.8 -113.6 %, the intra-assay precisión was 4.65 - 9.30% and, the inter-assay precisión was 6.84 - 7.50%. The assay was applied on 40 human plasma samples, the results were proportional and showed a positive correlation with no systematic differences to the determined by LC-MS/MS reference method.  Conclusion. The vancomycin detection assay using HPLC-UV was validated, showing high correlation with highly sensitive techniques (LC-MS/MS). The method proved to be selective, sensitive, and easy to implement in clinical laboratories with the aim of pharmacokinetically individualizing vancomycin doses.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[HPLC - UV]]></kwd>
<kwd lng="es"><![CDATA[LC - MS/MS]]></kwd>
<kwd lng="es"><![CDATA[vancomicina]]></kwd>
<kwd lng="es"><![CDATA[monitorización fármacoterapéutica (TDM)]]></kwd>
<kwd lng="en"><![CDATA[HPLC-UV]]></kwd>
<kwd lng="en"><![CDATA[LC-MS/MS]]></kwd>
<kwd lng="en"><![CDATA[vancomycin]]></kwd>
<kwd lng="en"><![CDATA[therapeutic drug monitoring (TDM)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elberdín Pazos]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Outeda Macías]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Salvador Garrido]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Martín Herranz]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La monitorización farmacocinética como nueva herramienta para individualizar la terapia anti-TNF]]></article-title>
<source><![CDATA[Farmacia Hospitalaria]]></source>
<year>2014</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>83-5</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escobar]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monitorización terapéutica de fármacos y aspectos prácticos de farmacocinética]]></article-title>
<source><![CDATA[Revista Médica Clínica Las Condes]]></source>
<year>2016</year>
<volume>27</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>605-14</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<collab>Food and Drug Administration</collab>
<source><![CDATA[Q2(R2) Validation of Analytical Procedures]]></source>
<year>2024</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[J.-H.]]></given-names>
</name>
<name>
<surname><![CDATA[Jeong]]></surname>
<given-names><![CDATA[S.-H.]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[H.-Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[Y.-B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of UPLC-MS/MS and HPLC-UV methods for the determination of zaltoprofen in human plasma]]></article-title>
<source><![CDATA[Journal of Pharmaceutical Investigaron]]></source>
<year>2019</year>
<volume>49</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>613-24</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucí]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Cucchiara]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ciofi]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Lastella]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Danesi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Di Paolo]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference mass spectrometry]]></article-title>
<source><![CDATA[Journal of Pharmaceutical and Biomedical Analysis]]></source>
<year>2020</year>
<numero>182</numero>
<issue>182</issue>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marks]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Duchein]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[I. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez]]></surname>
<given-names><![CDATA[H. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rivolta]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación de un método inmunológico para la determinación de vancomicina en líquido cefalorraquídeo]]></article-title>
<source><![CDATA[Revista de la Facultad de Ciencias Médicas de Córdoba]]></source>
<year>2019</year>
<volume>76</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paal]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Heilmann]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertsch]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Steinmann]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hóhl]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Liebchen]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Schuster]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kleine]]></surname>
<given-names><![CDATA[F. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Vogeser]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative LC-MS/MS and HPLC-UV analyses of meropenem and piperacillin in critically III patients]]></article-title>
<source><![CDATA[Clinical Laboratory]]></source>
<year>2019</year>
<volume>65</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1675-80</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsutsuura]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Moriyama]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kojima]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Mizukami]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Tashiro]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Osa]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Enoki]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Taguchi]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Oda]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Fujii]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Hamada]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Kimura]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Takesue]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Matsumoto]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The monitoring of vancomycin: A systematic review and meta-analyses of área under the concentration-time curve-guided dosing and trough-guideddosing]]></article-title>
<source><![CDATA[BMC Infectious Diseases]]></source>
<year>2021</year>
<numero>21</numero>
<issue>21</issue>
<page-range>153</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ye]]></surname>
<given-names><![CDATA[Z.-K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[H.-L.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhai]]></surname>
<given-names><![CDATA[S.-D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benefits of therapeutic drug monitoring of vancomycin: A Systematic Review and Meta-Analysis]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2013</year>
<volume>8</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
